Abstract
Prostate Specific Antigen (PSA) measurements are useful for early detection of prostate cancer and monitoring prostate cancer patients. However, there is the report that the initial PSA level is not necessarily associated with the prognosis of the prostate cancer patient. But there are few reports about the prognosis of the prostate cancer patients whose initial PSA are remarkably high (over 1000ng/ml). To determine the prognosis, we examined clinical course of the prostate cancer patients whose initial PSA were over 1000ng/ml.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
